Impact of Acid Inhibition on Esophageal Mucosal Injury Induced by Low-Dose Aspirin

Epidemiological study of gastro-oesophageal reflux disease: reflux in spouse as a risk factor

(2010) S. NASSERI-MOGHADDAM et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy Volunteers

(2009) Masafumi Nishino et al.   DIGESTIVE DISEASES AND SCIENCES

Esophageal Mucosal Injury With Low-Dose Aspirin and Its Prevention by Rabeprazole

(2009) Mitsushige Sugimoto et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial

(2009) Ali S Taha et al.   LANCET

Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study

(2008) P. RUSZNIEWSKI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

It Is Possible to Classify Non-erosive Reflux Disease (NERD) Patients into Endoscopically Normal Groups and Minimal Change Groups by Subjective Symptoms and Responsiveness to Rabeprazole—A Report from a Study with Japanese Patients

(2008) Motoyasu Kusano et al.   DIGESTIVE DISEASES AND SCIENCES